Titan Pharmaceuticals Inc (TTNP)
6.71
+0.01
(+0.15%)
USD |
NASDAQ |
May 02, 16:00
6.71
0.00 (0.00%)
After-Hours: 20:00
Titan Pharmaceuticals Cash from Investing (Quarterly): 0.504M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.504M |
| September 30, 2023 | 0.228M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -0.005M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.018M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.009M |
| September 30, 2020 | -0.444M |
| June 30, 2020 | -0.057M |
| March 31, 2020 | -0.03M |
| December 31, 2019 | -0.112M |
| September 30, 2019 | -0.061M |
| June 30, 2019 | -0.039M |
| March 31, 2019 | -0.044M |
| December 31, 2018 | -0.345M |
| September 30, 2018 | -0.018M |
| June 30, 2018 | 0.005M |
| March 31, 2018 | -0.058M |
| December 31, 2017 | -0.02M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.129M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.026M |
| December 31, 2016 | -0.075M |
| September 30, 2016 | -0.048M |
| June 30, 2016 | 0.009M |
| March 31, 2016 | -0.057M |
| December 31, 2015 | -0.077M |
| September 30, 2015 | -0.047M |
| June 30, 2015 | -0.002M |
| March 31, 2015 | -0.007M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.008M |
| June 30, 2014 | -0.008M |
| March 31, 2014 | -0.002M |
| December 31, 2013 | -0.021M |
| September 30, 2013 | 0.001M |
| June 30, 2013 | -0.118M |
| March 31, 2013 | -0.18M |
| December 31, 2012 | -0.032M |
| September 30, 2012 | -0.133M |
| June 30, 2012 | -0.467M |
| March 31, 2012 | -0.522M |
| December 31, 2011 | -0.178M |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.444M
Minimum
Sep 2020
0.504M
Maximum
Dec 2023
-0.0029M
Average
-0.009M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Outset Medical Inc | 23.42M |
| Allurion Technologies Inc | -0.398M |
| AIM ImmunoTech Inc | -0.214M |
| Protalix BioTherapeutics Inc | -0.342M |
| Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.246M |
| Cash from Financing (Quarterly) | 0.406M |
| Free Cash Flow | -7.092M |
| Free Cash Flow Per Share (Quarterly) | -2.972 |
| Free Cash Flow Yield | -140.5% |